Streetbeat News

Stock Prices

POOL

Pool Corporation reports that year-to-date sales are trending down approximately 6.5% from the comparable period in 2023.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 8:03 pm

KRUS

Over the past three months, 9 analysts have shared their insights on Kura Sushi USA (NASDAQ:KRUS), with ratings ranging from bullish to indifferent. The average 12-month price target has increased by 18.32% to $115.11. Recent analyst actions include maintaining, raising, and announcing new ratings and price targets.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 8:01 pm

BTCUSD

Bitcoin experienced a sharp decline, falling below $60,000, its lowest point since May. This drop led to $360 million in liquidations, with $148 million in Bitcoin longs. The largest single liquidation event was on Binance, involving a BTC/USDT position worth $15.36 million.

Portfolio Pulse from Murtuza Merchant

June 24, 2024 | 8:01 pm

VALN

Over the past three months, six analysts have evaluated Valneva (NASDAQ:VALN), with all ratings being bullish. The average 12-month price target remains at $26.00. Valneva's financials show a slight revenue decline but strong profitability and returns. However, the company faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 8:00 pm

SRE

Analysts have mixed ratings for Sempra (NYSE:SRE) with recent updates showing a blend of bullish and bearish perspectives. The average 12-month price target has increased to $81.25. Sempra faces revenue challenges but maintains strong net margins and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 8:00 pm

SRPT

Sarepta Therapeutics (NASDAQ:SRPT) has outperformed the market over the past 10 years with an average annual return of 18.37%, surpassing the market by 7.68% annually. A $1000 investment in SRPT 10 years ago would be worth $5,478.18 today.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 8:00 pm

CAT

Caterpillar (NYSE:CAT) has significantly outperformed the market over the past 15 years, delivering an average annual return of 16.6%. A $1000 investment in CAT 15 years ago would be worth $9,517.56 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 8:00 pm

POOL

Trading for POOL Corporation (POOL) was halted at 4:00:10 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 8:00 pm

NXL

Nexalin Technology has filed a prospectus for the sale of up to $7 million of common stock in a public offering, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:54 pm

PRAX

Needham initiated coverage on Praxis Precision Medicines Inc (NASDAQ:PRAX) with a Buy rating and a price target of $145. The company's lead product, ulixacaltamide, is in Phase 3 trials for essential tremor, with results expected in the second half of 2024. If successful, sales could peak at over $1 billion by 2030. Praxis also has other promising programs, including PRAX-628 for focal onset seizures and PRAX-562 for developmental and epileptic encephalopathies. The company's cash runway extends into 2027.

Portfolio Pulse from Vandana Singh

June 24, 2024 | 7:54 pm